Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenobamate cortical excitability biomarker study in refractory focal epilepsy
NL-OMON54069Completed
- Sponsor
- SEIN
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cenobamate in Focal Onset Epilepsy and epilepsy, sponsored by SEIN. Started Mar 2022; status: completed.
02
Drugs
cenobamate
03
Conditions
Focal Onset Epilepsyepilepsy
Beyond the preview
Go deeper on NL-OMON54069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54069.